Swiss healthcare firm Roche Diagnostics has launched a new diagnostics legal entity in Nigeria to deepen access to innovative healthcare and improve diagnostics capacity across West Africa.

André Hoffmann, the vice chairman and major shareholder of pharmaceutical giant Roche, sees protecting nature as the only ...

Late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Peter Ahnesorg is the new head of Roche Hungary’s pharmaceuticals division, replacing Raffaella Claudia Bondi, who led the ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

Swiss President Karin Keller-Sutter will visit pharma powerhouse Ireland tomorrow for high-level talks ahead of President ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Roche and Novartis have both recently announced ... Trump tariffs put pressure on Swiss pharma “If the proposed executive order goes into effect, the significant investments in the US we ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...

The top Swiss companies performed well in terms of sales and profits in 2024 in a difficult global environment, while large ...

<li /> 46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an aggressive cancer type with ...